CD8A and neoplasm: Immunohistochemistry (IHC) analysis demonstrated that both PD-L1 expression was upregulated in the DSF group as well as the DSF and anti-PD-1 Ab co-treatment group, while the population of tumor-infiltrating CD8+ T cells was downregulated in the tumor tissues of mice treated with DSF alone.